Temporal trends of thrombolysis treatment in Chinese acute ischemic stroke (AIS) patients from 2007 2017: analysis of China National Stroke Registry (CNSR) I, II, and III

Study identification

• EU PAS number:
  EUPAS33970
• Study ID:
  34431
• Official title and acronym:
  Temporal trends of thrombolysis treatment in Chinese acute ischemic stroke (AIS) patients from 2007 2017: analysis of China National Stroke Registry (CNSR) I, II, and III
• DARWIN EU® study:
  No
• Study countries:
  China
• Study description:
  Primary objectives: • To investigate the temporal changes in the proportion of intravenous recombinant plasminogen activator (IV rtPA) treatment from 2007 to 2017 among intravenous thrombolytics (IVT) eligible patients and overall AIS patients in China,• To investigate the temporal changes in IV rtPA treatment time intervals from 2007 to 2017 among IV rtPA treated patients in China.Secondary objectives: • To describe the demographic and clinical characteristics of the IV rtPA treated patients, IVT eligible patients and the overall AIS patients from the CNSR I to III.
• Study status:
  Planned

Research institutions and networks

Institutions

Beijing Tiantan Hospital

Study timelines

Date when funding contract was signed

Planned:30/04/2020

Study start date

Planned:15/05/2020

Data analysis start date

Planned:29/05/2020

Date of final study report

Planned:01/07/2020

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Boehringer Ingelheim

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable